11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial
- Contribution to journal › Article
- 2013
-
Mark
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
- Contribution to journal › Article
- 2012
-
Mark
Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus-Results of a Multicenter Trial.
- Contribution to journal › Article
-
Mark
Influence of HLA Matching on Heart Transplant Outcomes
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo
- Contribution to journal › Article
- 2011
-
Mark
Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients
- Contribution to journal › Article
-
Mark
Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden
- Contribution to journal › Debate/Note/Editorial
-
Mark
Efficacy and safety of continuous local infusion of ropivacaine after retroperitoneoscopic live donor nephrectomy
- Contribution to journal › Article
- 2010
-
Mark
Is Rituximab Safe to Use in Kidney Transplant Patients?
- Contribution to journal › Letter
- 2009
-
Mark
Subgroup Analyses in Randomized Controlled Trials: The Need for Risk Stratification in Kidney Transplantation
- Contribution to journal › Debate/Note/Editorial
